Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]
1 drugs in this class with 10,868 total adverse event reports.
1 Drugs
10,868 Total Reports
2,035 Serious Reports
287 Death Reports
| # | Drug Name | Generic Name | Reports | Serious | Deaths |
|---|---|---|---|---|---|
| 1 | Glecaprevir / Pibrentasvir | GLECAPREVIR AND PIBRENTASVIR | 10,868 | 2,035 | 287 |